<DOC>
	<DOCNO>NCT02390258</DOCNO>
	<brief_summary>This study evaluation safety tolerability XEN-D0103 healthy subject . Part 1 ass safety , tolerability blood level ascend single dos XEN-D0103 . Blood level XEN-D0103 assess administer food also without food Part 2 . The safety , tolerability blood level XEN-D0103 assess follow dose 10 day Part 3 .</brief_summary>
	<brief_title>Fed-Fasted , Single Multiple Ascending Dose Trial XEN-D0103</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>For Parts 1 3 healthy , male subject age 18 45 year , inclusive . For Part 2 healthy , male female subject age 45 65 year , inclusive . Females must nonchildbearing potential Subject know heart disease . Subject QTcF &gt; 450 msec , PR ≥ 210 msec QRS ≥ 120 msec screening ( determined median three reading ) . For Part 1 : subject rest heart rate outside range 45 80 beat per minute ( bpm ) screening ( determined median three reading ) . Subject condition , investigator 's opinion interfere trial . Subject systolic blood pressure ( BP ) &lt; 80 &gt; 160 mmHg screen diastolic BP &gt; 90 &lt; 45 mmHg screening . Subject clinically significant abnormal laboratory test result screening . Female subject pregnant breast feed female subject childbearing potential .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>